Accelerate Diagnostics Inc. buy melinda
Start price
15.10.18
/
50%
€144.73
Target price
12.02.19
€184.91
Performance (%)
18.39%
End price
12.02.19
€171.34
Summary
This prediction ended on 12.02.19 with a price of €171.34. The prediction had a final performance of 18.39%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Accelerate Diagnostics Inc. | - | - | - | - |
| iShares Core DAX® | -0.383% | 5.021% | 16.188% | 19.224% |
| iShares Nasdaq 100 | 1.248% | 4.007% | 36.579% | 57.508% |
| iShares Nikkei 225® | 0.525% | -0.109% | 12.378% | 9.329% |
| iShares S&P 500 | 0.640% | 3.649% | 28.752% | 47.932% |
Comments by melinda for this prediction
In the thread Accelerate Diagnostics Inc. diskutieren
SecteurEquipement et technologie médicale avancés Agenda 07/11 Publication de résultats
Focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens
Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections.
It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens.
The company was founded on May 26, 1982 and is headquartered in Tucson, AZ.
Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections.
It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens.
The company was founded on May 26, 1982 and is headquartered in Tucson, AZ.
Nombre d'employés : 239 personnes.
(Vom Mitglied beendet)
Stopped prediction by melinda for Accelerate Diagnostics Inc.
Accelerate Diagnostics Inc.
Start price
Target price
Perf. (%)
€16.00
30.08.22
30.08.22
€20.00
30.08.23
30.08.23
-57.19%
31.08.23
31.08.23
Accelerate Diagnostics Inc.
Start price
Target price
Perf. (%)
€59.00
14.12.20
14.12.20
€100.00
14.12.21
14.12.21
-28.81%
15.12.21
15.12.21
Accelerate Diagnostics Inc.
Start price
Target price
Perf. (%)
€90.50
12.03.20
12.03.20
€150.00
04.11.21
04.11.21
-34.81%
14.12.20
14.12.20
Accelerate Diagnostics Inc.
Start price
Target price
Perf. (%)
€200.24
18.09.18
18.09.18
€207.01
19.09.18
19.09.18
3.38%
19.09.18
19.09.18